Reason: Lack of Assurance of Sterility
Distributed: US NationwideReason: Lack of Assurance of Sterility
Distributed: US NationwideReason: Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C.
Distributed: U.S. Nationwide.Reason: Product Mix Up. A bottle of Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.
Distributed: Nationwide within the United StatesReason: Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR.
Distributed: Nationwide within the United StatesReason: Failed Impurities/Degradation Specifications.
Distributed: Nationwide within the United StatesReason: Failed Impurities/Degradation Specifications.
Distributed: Nationwide within the United StatesReason: Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as pantoprazole tablet 20mg.
Distributed: Nationwide in the USAReason: Labeling: Not Elsewhere Classified: Back Label states 'Each contains: cephalexin monohydrate, USP equivalent to 5g' instead of Each Bottle contains: cephalexin monohydrate, USP equivalent to 10g'
Distributed: Nationwide in the USAReason: Labeling: Not Elsewhere Classified: Back Label states Each contains: cephalexin monohydrate, USP equivalent to 5g' on the back label instead of Each Bottle contains: cephalexin monohydrate, USP equivalent to 5g'
Distributed: Nationwide in the USA